Filter by: patients
What is Banzel?

Banzel™ is a brand name for rufinamide, an anticonvulsant agent used for adjunctive therapy in the treatment of generalized seizures of Lennox-Gastaut syndrome.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Epilepsy 10 6 Efficacy_major Efficacy_moderate Efficacy_slight
Seizures (complex partial) 1 0

See all 13 patients currently taking Banzel

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
2
Mild
3
None
1

Reported Dosages

  400 mg daily 800 mg daily 1,200 mg daily 1,600 mg daily 2,400 mg daily 3,200 mg daily
  2 Number of Patients: 2 3 Number of Patients: 3 2 Number of Patients: 2 3 Number of Patients: 3 1 Number of Patients: 1 4 Number of Patients: 4  

Reported Stop Reasons

Why Patients Stopped Taking Banzel (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 1   Side effects too severe: 100%

See all 1 patient who’ve stopped taking Banzel

Currently Taking Banzel

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Stopped Taking Banzel

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Banzel

Always
6 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Banzel

Very
0 0%
Somewhat
0 0%
A little
1 17%
Not at all
5 83%

Cost

Paid out of pocket

Cost of Banzel

$200+
1 25%
$100-199
0 0%
$50-99
1 25%
$25-49
1 25%
< $25
1 25%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 27, 2012.